Metraipolis › archive › dc_4d1059ae33fa
Class-Specific Effects of ARBs Versus ACE Inhibitors on Survival and Cardiovascular Outcomes in MASLD — Europe PMC PMID:41155354
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41155354
- DOI
- 10.3390/ijms262010061
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T06:23:57.253Z
- SHA-256 of the archived text
2b0745cf12ed92eca2a46b5a069f5610ee4666300e206dc5d0281aa8cc491516- Stable URL of this page
https://metraipolis.com/documento/dc_4d1059ae33fa
How to cite
Class-Specific Effects of ARBs Versus ACE Inhibitors on Survival and Cardiovascular Outcomes in MASLD — Europe PMC PMID:41155354 — Europe PMC (en), https://europepmc.org/article/MED/41155354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4d1059ae33fa (Metraipolis archive dc_4d1059ae33fa, sha256 2b0745cf12ed92eca2a46b5a069f5610ee4666300e206dc5d0281aa8cc491516)
BibTeX
@misc{dc4d1059ae33fa,
title = {Class-Specific Effects of ARBs Versus ACE Inhibitors on Survival and Cardiovascular Outcomes in MASLD — Europe PMC PMID:41155354},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41155354},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4d1059ae33fa; sha256 2b0745cf12ed92eca2a46b5a069f5610ee4666300e206dc5d0281aa8cc491516},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155354. Agents can read the archived copy with the MCP tool read_document.